GVR Report cover Asia Pacific Disposable Endoscopes Market Size, Share & Trends Report

Asia Pacific Disposable Endoscopes Market Size, Share & Trends Analysis Report By Application (Bronchoscopy, Urologic Endoscopy, Arthroscopy, GI Endoscopy, ENT Endoscopy), By End Use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-956-3
  • Number of Report Pages: 150
  • Format: PDF, Horizon Databook
  • Historical Range: 2017 - 2020
  • Forecast Period: 2022 - 2030 
  • Industry: Healthcare

Report Overview

The Asia Pacific disposable endoscopes market size was valued at USD 495.2 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.8% from 2022 to 2030. The increasing population and growing burden of chronic and functional gastrointestinal disorders, such as cardiovascular diseases, diabetes, & cancer, in Asia Pacific are some of the major factors anticipated to drive the market growth. In addition, the increasing number of endoscopic procedures and the preference to reduce the chances of cross-contamination for better clinical outcomes are also expected to boost the market growth in the forecast period.

 Japan disposable endoscopes market size, by application, 2020 - 2030 (USD Million)

Infection from reusable endoscopes poses a significant risk to healthcare providers. Inadequate sterilization of reusable endoscopes can cause life-threatening infections, which reduces their adoption and is anticipated to increase the use of single-use endoscopes, driving market growth over the forecast period. Growing investments by the government and modern healthcare infrastructure are also expected to drive market growth over the years. The increasing geriatric population, growing incidence of functional chronic upper abdominal pain or dyspepsia due to irritable bowel syndrome, and rising prevalence of irritable bowel syndrome are a few factors expected to accelerate the adoption of single-use endoscopes over the forecast period.

For instance, an article published in 2019 in the Journal of Neurogastroenterology and Motility stated that the prevalence of dyspepsia in irritable bowel syndrome patients is 58.0% in India, 25.0% to 64.0% in China, and 14.0% in South Korea. The growing number of product launches by the endoscopic device manufacturers in the Asia Pacific region and increasing recommendation by the FDA to manufacture single-use endoscopic devices due to concerns about disease transmission through reusable endoscopes are expected to impel market growth over the forecast period.

COVID-19 Disposable Endoscopes Estimated Market Impact: 29.4% Increase In Revenue Growth From 2019 To 2020

Pandemic Impact

Post-COVID-19 Outlook

The Asia Pacific disposable endoscopes market grew by around 29.4% from 2019 to 2020.

The market is projected to witness a year-on-year growth of approximately 20% to 30% in the coming 5 years.

The risk of coronavirus infection has increased the adoption of disposable endoscopes and their components by the healthcare facilities performing endoscopic procedures, to eliminate cross-contamination and related infections. This impelled market growth during the COVID-19 pandemic.

The FDA recommends developing and launching disposable endoscopic units to minimize the chances of contamination; this is one of the major factors anticipated to drive the market growth over the forecast years.


Fast recovery time, shorter hospital stay, and lower post-procedure complications coupled with reducing maintenance costs are some of the major factors supporting the growth of the market during the pandemic.

Furthermore, the growing prevalence of communicable and noncommunicable diseases coupled with increasing industry consolidation activities by the manufacturers is expected to fuel growth during the post-pandemic period.


For instance, in April 2021, Olympus, a Japan-based company, launched its first single-use bronchoscope, a device designed to simplify clinical workflow by reducing the chances of cross-contamination and maintenance costs. The growing cases of COVID-19 infection and increasing fear of transmission of the infection are anticipated to accelerate the adoption of disposable medical devices. Lower maintenance cost and chances of contamination of disposable endoscopic devices have also propelled their adoption in the Asia Pacific region during the COVID-19 pandemic.

Application Insights

By application, the bronchoscopy segment dominated with a revenue share of around 29% in 2021. This high share of the segment can be attributed to the growing prevalence of respiratory diseases in Asia Pacific. Furthermore, the growing prevalence of pulmonary hypertension, Chronic Obstructive Pulmonary Disease (COPD), respiratory allergies, asthma, occupational lung disease, and infections caused by the use of reusable bronchoscopes supported the adoption of disposable bronchoscopes in the region.

Furthermore, technological advancements and the growing adoption of ear, nose, & throat endoscopic procedures, coupled with increasing concern about infections due to the use of reusable ENT endoscopes, are expected to support the growth of the segment. The growing prevalence of sinus infections, asthma, obstructive pulmonary disease (COPD), and respiratory allergies increases the number of endoscopic procedures, which is thereby anticipated to drive the market growth during the forecast period.

End-use Insights

By end-use, the hospital segment accounted for the highest revenue share of over 47% in 2021. This revenue share can be attributed to the increasing number of endoscopic procedures performed in hospitals and the growing patient preference for hospitals for the diagnosis of diseases. In addition, the growing number of modern hospitals in Asia Pacific with facilities for endoscopy, the cost-effectiveness of using disposable endoscopes & their components, and favorable reimbursement policies are also anticipated to fuel the growth of the segment.

 Asia Pacific disposable endoscopes market share, by end-use, 2021 (%)

The growing adoption of disposable endoscopic devices by clinics for better patient engagement is anticipated to drive segment growth over the forecast period. In addition, low maintenance costs & lower chances of contamination of single-use endoscopic devices, and advantages such as quick recovery time, cost-effectiveness, & shorter clinical stay are also expected to accelerate segment growth over the forecast period.

Regional Insights

Japan is anticipated to have a high revenue share of about 38.0% in 2021 in the Asia Pacific region owing to the growing adoption of single-use endoscopes and an increase in the number of endoscopic procedures. In addition, the growing prevalence of communicable & noncommunicable diseases and the rise in government initiatives for use of disposable endoscopes to minimize the chances of contamination are also anticipated to drive the Japanese market in this region.

Furthermore, the market in China is also expected to grow at a fast CAGR during the forecast period, owing to increasing awareness about reducing contamination due to reusable endoscopes as well as improving healthcare infrastructure. In addition, the high overall population; the growing geriatric population, which is prone to several chronic disorders; the increasing number of global & local endoscopic device manufacturers & their growing focus on the development of disposable endoscopes are further anticipated to drive market growth in China during the forecast period.

Key Companies & Market Share Insights

Several industry consolidation activities, such as mergers & acquisitions, and partnerships have resulted in a strong market share of the Asia Pacific region. Manufacturers in the global endoscopic devices market are also focusing on launching new disposable endoscopes with advanced features as per patients’ requirements, to enhance their market share and consumer base in the Asia Pacific region.Some prominent players in the Asia Pacific disposable endoscopes market include:

  • Ambu A/S

  • Prosurg Inc. (Neoscape, Inc.)

  • AirStrip Technologies

  • Boston Scientific Corporation

  • Parburch Medical

  • OBP Medical Corporation

  • Welch Allyn (Hill-Rom Services Inc.)

  • Allscripts Healthcare Solutions

  • Flexicare Medical Limited

  • Timesco Healthcare Ltd.

  • Sunmed

Asia Pacific Disposable Endoscopes Market Report Scope

Report Attribute


Market size value in 2022

USD 605.6 million

Revenue forecast in 2030

USD 2.4 billion

Growth rate

CAGR of 18.8% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, end-use, region

Regional scope

Asia Pacific

Country scope

Japan; China; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines

Key companies profiled

Ambu A/S; Prosurg Inc. (Neoscape, Inc.); AirStrip Technologies; Boston Scientific Corporation; Parburch Medical; OBP Medical Corporation; Welch Allyn (Hill-Rom Services Inc.); Allscripts Healthcare Solutions; Flexicare Medical Limited; Timesco Healthcare Ltd.; Sunmed

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Asia Pacific Disposable Endoscopes Market Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the Asia Pacific disposable endoscopes market report based on application, end-use, and region:

 Asia Pacific Disposable Endoscopes Segmentation

  • Application Outlook (Revenue, USD Million, 2017 - 2030)

    • Bronchoscopy

    • Urologic endoscopy

    • Arthroscopy

    • GI endoscopy

    • ENT endoscopy

    • Others

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospitals 

    • Clinics

    • Diagnostics Centers

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • New Zealand

      • Thailand

      • Indonesia

      • Malaysia

      • Vietnam

      • Philippines

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.